Paid Clinical Trials Portland

Discover 167 paid clinical trials in Portland, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 167

Pirtobrutinib & ObinutuzumabFixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Inhye Ahn

Location:

Scarborough ME, Boston MA

Code:

NCT06333262

Conditions

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pirtobrutinib

Obinutuzumab

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Scarborough ME, Boston MA, Lebanon NH, Bangor MEshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

CamizestrantAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Scarborough ME, Hooksett NH, Manchester NH, Boston MAshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

SaruparibSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Scarborough ME, Providence RI, Norwich CT, Albany NYshow 115 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

SelinexorSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Scarborough ME, Boston MA, Albany NY, Montrealshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

EvolocumabEffect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Recruiting

Sponsor:

Unity Health Toronto

Location:

Portland ME, New Haven CT, Quebec, Kingstonshow 5 more

Code:

NCT03900026

Conditions

Coronary Artery Bypass Graft Surgery

Atherosclerosis

Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evolocumab

Placebo

Paclitaxel & IpatasertibStudy of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Scarborough ME, Augusta ME, Boston MA, Brewer MEshow 165 more

Code:

NCT05554380

Conditions

Locally Advanced Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Ipatasertib

Magnetic Resonance Imaging

JNJ-81201887A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Portland ME, Liverpool NY, Baltimore MD, Hagerstown MDshow 29 more

Code:

NCT06635148

Conditions

Geographic Atrophy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

JNJ-81201887

Sham Procedure

Immunotherapy with ChemotherapyTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

South Portland ME, Biddeford ME, Sanford ME, Norway MEshow 741 more

Code:

NCT04267848

Conditions

Lung Non-Small Cell Carcinoma

Lung Non-Small Cell Squamous Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

Echocardiography Test

RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Augusta ME, Boston MA, Albany NY, East Setauket NYshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo